You are using an outdated browser. Please
upgrade your browser to improve your experience.
Rhenium-SCT® (Skin Cancer Therapy) is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for the treatment Non-Melanoma Skin Cancer
Oncobeta WeBe
by Oncobeta WeBe
What is it about?
Rhenium-SCT® (Skin Cancer Therapy) is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for the treatment Non-Melanoma Skin Cancer. The main objective of the Rhenium-SCT® is to be a painless, personalized, non-invasive therapy targeting and destroying cancer cells in the area needed to treat. This mobile application is to capture information from patients that have received Rhenium-SCT® treatment.
App Screenshots
App Store Description
Rhenium-SCT® (Skin Cancer Therapy) is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for the treatment Non-Melanoma Skin Cancer. The main objective of the Rhenium-SCT® is to be a painless, personalized, non-invasive therapy targeting and destroying cancer cells in the area needed to treat. This mobile application is to capture information from patients that have received Rhenium-SCT® treatment.
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
